export const caseStudyCardsData = [
  {
    title: "GLOBAL PATIENT CASE DEMAND STUDY",
    text: "Global demand study for a rare type of hematological cancer with complex treatment dynamics",
    img: "../caseStudiesAssets/Global-Patient-384x384.png",
  },
  {
    title: "EARLY-STAGE DEMAND RESEARCH",
    text: "Global demand study for an early-stage oncology treatment in a high unmet need category",
    img: "../caseStudiesAssets/Early-Demand-384x384.png",
  },
  {
    title: "PIPELINE FORECAST",
    text: "Global model for oncology condition with a complex patient flow",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Pipeline.webp",
  },
  {
    title: "ON-MARKET PRODUCT FORECAST",
    text: "Forecasting with higher accuracy and greater versatility in a competitive market",
    img: "../caseStudiesAssets/Viscadia-Case-Study-On-Market.webp",
  },
  {
    title: "GLOBAL LAUNCH FORECAST MODELING",
    text: "Global launch forecast planning for an oncology asset",
    img: "../caseStudiesAssets/case-study-img7-500x500.webp",
  },
  //test
  {
    title: "GROSS TO NET (GTN) MODELING",
    text: "Designing a dynamic tool for detailed gross to net revenue modeling",
    img: "../caseStudiesAssets/case-study-img8-500x500.webp",
  },
  {
    title: "LONG RANGE FORECAST PLANNING",
    text: "Long range planning platform for portfolio assessment",
    img: "../caseStudiesAssets/case-study-img9-500x500.webp",
  },
  {
    title: "STRATEGY AND PORTFOLIO OPTIMIZATION",
    text: "Patient-level forecasting for four on-market products with $1B+ in total revenue",
    img: "../caseStudiesAssets/Viscadia-Case-Study-On-market-Portfolio-Forecast-Management.webp",
  },
  {
    title: "GO-TO-MARKET MODEL",
    text: "In-depth patient forecasting and tracking for a rare disease product",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Go-to-market-forecast-model.webp",
  },
  {
    title: "GLOBAL ONCOLOGY FORECASTING",
    text: "Building forecasting capabilities for a multi-national life science company",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Global-Oncology-Forecast-Model.webp",
  },
  {
    title: "PAIN MANAGEMENT PORTFOLIO FORECAST",
    text: "Designing a specialized forecast model for pain management portfolio",
    img: "../caseStudiesAssets/case-study-img10-500x500.webp",
  },
];

export const caseStudyDetailsData = [
  {
    id: 1,
    urlTitle: "Global Patient Case Demand Study",
    img: "../caseStudiesAssets/Global-Patient-384x384.png",
    title:
      "Global demand study for a rare type of hematological cancer with complex treatment dynamics",
    texts: [
      "A clinical biopharmaceutical company sought to understand the market potential of a novel, late-stage pipeline drug candidate for a rare form of blood cancer.",
      "Viscadia was tasked with designing and conducting an in-depth demand study in key global markets to gain insights into the current market landscape and future developments, and to inform the forecast model based on the study’s findings.",
    ],
    mainSubtitle:
      "Assisted the client in evaluating the product's potential across various patient segments and equipped the forecast for a successful launch planning",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Product-Position.png",
        title: "Product’s positioning amidst evolving market dynamics",
        texts: [
          "Current treatment options comprise a mix of newly launched branded targeted therapies and generic.",
          "A recently approved branded therapy for frontline use is disrupting the treatment paradigm.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Complex-Patient-1.png",
        title:
          "Complex patient segmentation based on eligibility and prior treatment history",
        texts: [
          "Patient segmentation, including prior treatment history, vital for identifying the product’s potential versus competitors.",
          "Variations in the potential product label also crucial in identifying the target patient opportunity.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Accelrated.png",
        title: "Accelerated timeline to meet cross functional needs",
        texts: [
          "An updated forecast incorporating the demand study findings was necessary to drive operational and financial decisions.",
          "A new round of investments depended on the updated forecast metrics.",
        ],
      },
    ],
    approach: [
      {
        title: "Patient case study",
        texts: [
          "Realistic patient cases incorporating the key patient characteristics influencing treatment decisions served as context for the research.",
          "Patient profiles included key characteristics such as prior therapy received and their response, making them more realistic.",
          "Patient simulation allowed for estimation of shares at both segment and sub-segment levels within each line of therapy.",
        ],
      },
      {
        title: "Global Quantitative Survey",
        texts: [
          "Online surveys were conducted globally across major geographies with over 250 physicians combined across key specialties and practice settings",
        ],
      },
      {
        title: "Multiple product label scenarios",
        texts: [
          "Respondents’ treatment choices were evaluated across multiple product scenarios to assess their receptivity towards different potential product labels.",
        ],
      },
      {
        title: "Post-Survey Calibration",
        texts: [
          "A robust share calibration methodology was adopted to triangulate physician-stated responses",
          "with real-world dynamics and to adjust for HCP overstatement in anticipated prescribing.",
        ],
      },
      {
        title: "Competitor impact",
        texts: [
          "Assessed awareness of the recent front-line approval of a key competitor and its potential impact on physicians’ current treatment choice selection.",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Global study readout with key insights around prescribing behavior and analyses around product potential for each geography.",
          "Patient case simulator to investigate preference share estimates across different patient segments.",
          "Updated forecasts and scenarios for each geography based on the outputs from the demand study.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Physicians preferred the product for later rather than earlier lines of therapy, due to the lack of direct comparison trials with existing treatment options.",
          "US physicians prioritized the product’s efficacy over safety, while EU physicians expressed greater concern about safety, leading to lower overall prescribing rates in the EU compared to the US.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Insights from the demand study and the forecast updates supported successful launch planning and played a key role in securing additional investments prior to launch.",
          "Helped identify product characteristics that differentiated the new product relative to competitors.",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Global-Patient-Demand_(1).pdf",
  },
  {
    id: 2,
    urlTitle: "Early-Stage Demand Research",
    img: "../caseStudiesAssets/Early-Demand-384x384.png",
    title:
      "Global demand study for an early-stage oncology treatment in a high unmet need category",
    texts: [
      "A global pharmaceutical company wanted to understand the market potential for a new therapy in a highly competitive oncology space. Viscadia was asked to design and conduct an early-stage demand study in key global markets to support an updated forecast and a go/no-go decision regarding further clinical development.",
    ],
    mainSubtitle:
      "Demand study and updated forecast supported further clinical development for the asset.",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Significant.png",
        title: "Significant clinical uncertainty",
        texts: [
          "Demonstrating clinical benefit vs SOC has been difficult, as illustrated by several recent clinical trial failures in Phase II and Phase III.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Crowded.png",
        title: "Crowded market with several new competitors",
        texts: [
          "Large number of potential entrants incorporating various new treatment modalities.",
          "Timing and order of entry may limit market potential for later entrants differentiation vs. established therapies.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Product-Position.png",
        title: "Strategic importance",
        texts: [
          "Category with a large patient population and high unmet need in second and later lines of treatment.",
        ],
      },
    ],
    approach: [
      {
        title: "Product Conjoint Design",
        texts: [
          "For eligible patients, investigating sensitivity of results to variations in clinical performance for new products.",
        ],
      },
      {
        title: "Primary Markets Research",
        texts: [
          "N=400 online interviews conducted across key geographies in the US, EU, and Japan. For eligible patients, investigating sensitivity of results to variations in clinical performance for new products.",
          "N=20 follow-up qualitative interviews to deep-dive into the why’s underlying oncologists’ prescribing decisions.",
        ],
      },
      {
        title: "Forecast Update",
        texts: [
          "Incorporated demand study outcomes to update the revenue projections for the treatment under consideration.",
        ],
      },
      {
        title: "Post-Survey Calibration",
        texts: [
          "Ensured shares accurately reflected current market dynamics by adjusting for HCP overstatement in anticipated prescribing.",
        ],
      },
      {
        title: "Developed forecast platform",
        texts: [
          "Customized platform for the product opportunity that allowed for dynamic, comprehensive evaluation of key performance drivers, and enabled scenario comparison and contrasting",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Global PowerPoint report highlighting key analyses and insights for each geography",
          "Excel-based market simulator allowed the client to conduct sensitivity analyses, estimate product attribute importance scores, and investigate “what-if” scenarios for key patient segments and market scenarios.",
          "Updated global forecast.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Simultaneous management of the demand study and forecast model ensured synergy, enhancing study completeness and facilitating seamless integration of outcomes into the forecast framework.",
          "Enabled timely forecast updates to integrate into the long-range plan, driving pivotal corporate strategy decisions.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Facilitated the leadership team in presenting a compelling case for continuing clinical development to executives and investors.",
          "Empowered leadership to assess returns and strategically choose between independent pursuit or strategic partnership for the asset.",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Early-Demand-Research_(2).pdf",
  },
  {
    id: 3,
    urlTitle: "Pipeline Forecast",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Pipeline.webp",
    title: "Global model for oncology condition with a complex patient flow",
    texts: [
      "A large global pharmaceutical company wanted to better understand the product potential of a late-stage, highly targeted pipeline drug candidate for immunotherapy. This drug was indicated for a complex, underserved therapeutic condition.",
      "Viscadia was asked to design and build a custom forecast model spanning all global regions and accommodating key therapeutic and commercial drivers of product performance.",
    ],
    mainSubtitle:
      "Client gained unprecedented buy-in from 15 regional counterparts and global HQ",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Complex-1.png",
        title: "Complex patient flow and treatment paradigm",
        texts: [
          "Multiple indications and lines of therapy constituting an interlinked treatment paradigm, with regional variations in physician preferences and demographic nuances",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Staggered.png",
        title: "Staggered launches,Non-promoted usage",
        texts: [
          "Underserved therapy area combined with multiple indications and staggered launches, leading to significant potential in non-promoted usage",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Cross-Funcitonal.png",
        title: "Cross-functional stakeholder management",
        texts: [
          "Regional stakeholders from 15 participating geographies",
          "Multiple third-party vendor/partners conducting supporting research",
          "Senior management at global HQ responsible for global forecast",
        ],
      },
    ],
    approach: [
      {
        title: "Executed in-depth therapy-area research",
        texts: [
          "Assessed therapy-area nuances, clinical and commercial drivers of product usage, and shift in treatment paradigms driven by imminent pipeline approvals",
        ],
      },
      {
        title: "Conducted analogue research",
        texts: [
          "Identified and evaluated uptake performances of recent key launches to drive uptake assumptions",
        ],
      },
      {
        title: "Supported design of primary market research (PMR)",
        texts: [
          "Identified relevant analogues to develop a perspective on pricing and implications of the ensuing access constraints on product uptake",
        ],
      },
      {
        title: "Developed forecast platform",
        texts: [
          "Customized platform for the product opportunity that allowed for dynamic, comprehensive evaluation of key performance drivers, and enabled scenario comparison and contrasting",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Standard patient flow design harmonizing variations and commonalities in forecasting approach across global regions",
          "Forecast platform with a comprehensive set of output views and summaries addressing cross-functional stakeholders",
          "Efficient interface to facilitate easy aggregation of forecast results across global regions",
          "Geography-specific thought leadership on prioritizing action plan leading up to launch",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Successfully collaborated and worked harmoniously alongside multiple third-party vendors",
          "Delivered support and leadership to stakeholders from 15 global regions across multiple time zones",
          "Conducted live workshops to drive adoption and support for new forecasting platform among multiple stakeholders",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "U.S. leadership gained unprecedented buy-in from all regional counterparts and Global HQ on asset potential",
          "Client successfully moved the asset to Phase III of clinical trials following global opportunity assessment",
          "Established an end-to-end forecasting process which eventually defined best practices across multiple pipeline assets",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Pipeline-Forecast-_(3).pdf",
  },
  {
    id: 4,
    urlTitle: "On-Market Product Forecast",
    img: "../caseStudiesAssets/Viscadia-Case-Study-On-Market.webp",
    title:
      "Forecasting with higher accuracy and Greater versatility in a competitive market",
    texts: [
      "A large pharmaceutical/biotechnology company wanted to better understand the product potential of an on-market, non-retail drug distributed through a limited network of specialty pharmacies and distributors in an active, competitive environment.",
      "Viscadia was asked to build a custom forecast model that could integrate seamlessly with the client’s existing Latest Estimate (LE) process and that would also be versatile enough to support multiple stakeholders and the long-term brand planning process.",
    ],
    mainSubtitle: "Increase in accuracy compared to previous forecast model",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Complex-1.png",
        title: "Data complexity",
        texts: [
          "Product and distribution model involving multiple and disparate data sources",
          "IntegriChain (unit demand, inventory)",
          "Patient data (enrollments, restarts)",
          "Internal (finance, ex-factory)",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Market-Event-1.png",
        title: "Market event modeling in absence of competitor data",
        texts: [
          "Specialty (non-retail) distribution model across all competitors hindered the availability of market data, and complex market events were impacting product performance — increasing the complexity of the required modeling",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Cross-Funcitonal.png",
        title: "Cross-functional stakeholder needs",
        texts: [
          "Sales, marketing and finance each had distinct objectives for the model, including harmonization of the unit-demand forecast with patient enrollments",
        ],
      },
    ],
    approach: [
      {
        title: "Improved user experience",
        texts: [
          "Built an organic model with a streamlined flow, incorporating VBA-driven automation, with complete transparency and user-friendly design",
        ],
      },
      {
        title: "Mapped cross-functional stakeholder needs",
        texts: [
          "Identified discrete needs across sales, marketing and finance stakeholders and created customized outputs to meet requirements",
        ],
      },
      {
        title: "Modeled complex market events",
        texts: [
          "Assimilated market research (AMUs) to understand and model for multiple market events using diffusion curves",
        ],
      },
      {
        title: "Designed multiple forecasting pathways",
        texts: [
          "Created capabilities for users to choose from multiple forecasting pathways (unit demand vs. patient enrollments) that were harmonized across the platform",
        ],
      },
      {
        title: "Embedded in-house forecasting palette",
        texts: [
          "Integrated a robust and transparent statistical palette (Exponential Smoothing, Holt-Winters, Box-Jenkins, etc.) resulting in improved forecast accuracy and model flexibility",
        ],
      },
      {
        title: "Developed forecast platform",
        texts: [
          "Customized platform for the product allowed for dynamic, comprehensive evaluation of key performance drivers, and served cross-functional stakeholder objectives",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Forecast platform with a comprehensive set of output views and summaries addressing cross-functional stakeholders",
          "User manual providing extensive documentation of model design and operation to facilitate easy knowledge transfer",
          "Executive slides to facilitate quarterly LE discussions, generated by an automated module within the model",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Reduced the MAPE (mean absolute percentage error) by nearly 50% in actual vs. forecast for the new model compared to the existing model",
          "Dynamically modeled for five major market events occurring at different times in the forecast horizon",
          "Successfully enabled the forecast team to tie the revenue forecast to weekly patient enrollment targets for the sales team",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Reduced workflow for quarterly LE from ~40 hours to ~8 hours",
          "New model served as the base platform for future Life Cycle Management (LCM) strategy scenario-planning exercises",
          "Client asked Viscadia to design and build a new model for another product within the same franchise",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_On-Market-Product-Forecast-_(4).pdf",
  },
  {
    id: 5,
    urlTitle: "Global Launch Forecast Modeling",
    img: "../caseStudiesAssets/case-study-img7-500x500.webp",
    title: "Global launch forecast planning for an oncology asset",
    texts: [
      "A large global pharmaceutical company wanted to better understand the product potential of a HER3 directed ADC for the treatment of patients with metastatic NSCLC",
      "Viscadia was tasked with designing and building custom forecast platforms and processes catering to the U.S., EU5, Japan, and China to support cross-functional stakeholder objectives leading up to its launch",
    ],
    mainSubtitle:
      "Successfully established robust forecast capabilities across regions and enabled smooth launch forecast planning",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Complex-Patient-1.png",
        title: "Complex patient segmentation based on treatment history",
        texts: [
          "Tracking patients across multiple lines of therapy",
          "Segmenting eligible patients based on treatment history and availability of inputs",
          "Mapping patient opportunity based on patient journey across the lines of therapy",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Lack-of-standard.png",
        title: "Lack of standard forecast model and process across regions",
        texts: [
          "Different forecasting processes across geographies",
          "Multiple disconnected forecast narratives at the regional and global HQ level",
          "Incorporating region-specific nuances such as pricing and patient access",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Growing-Need.png",
        title: "Growing need for a comprehensive forecast storyboard",
        texts: [
          "Simulating several what if forecast scenarios across geographies",
          "Consolidating forecast models’ regions to form a clean forecast storyboard",
        ],
      },
    ],
    approach: [
      {
        title: "Gap analysis",
        texts: [
          "Conducted in-depth interviews with global and regional stakeholders.",
          "Audited literature and deep dived into existing forecast models",
        ],
      },
      {
        title: "Patient journey and segmentation",
        texts: [
          "Designed patient segments to account for patient’s treatment choice in each line of therapy.",
          "Aligned treatment eligibility and patient opportunity segments",
        ],
      },
      {
        title: "Regional forecasting nuances",
        texts: [
          "Collaborated with stakeholders to incorporate regional nuances into the forecast model flow",
          "Devised developed a comprehensive forecasting framework that could scale across regions",
        ],
      },
      {
        title: "Market share modeling and event impact",
        texts: [
          "Designed market share modeling framework by calibrating inputs from the physician research",
          "Modeled event impact due to competitor launches at the segment level",
        ],
      },
      {
        title: "Pipeline forecast model and global forecast aggregator",
        texts: [
          "Design and built patient flow forecast models for each region",
          "Built a global forecast model aggregator for the headquarters to assimilate forecasts from different regions",
        ],
      },
      {
        title: "Forecast analytics and storyboards",
        texts: [
          "Designed clear, comprehensive and actionable forecast summaries for executive decision making",
          "Automated the workflow of consolidating regional forecast scenarios into a single storyboard",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Viscadia Global Forecast Model (For headquarters)",
          "Viscadia Regional Forecast Models (For individual countries)",
          "Different aggregator models for EU and Global teams",
          "User guide for stakeholder training",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Streamlined the global forecasting process through deep collaboration",
          "Established new forecasting infrastructure and facilitated stakeholder onboarding",
          "Led forecast stakeholders from 8 global regions towards forecasting best practices",
          "Conducted live workshops to drive adoption and support for new forecasting platform",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Successfully established robust forecast capabilities across regions and enabled smooth launch forecast planning",
          "Patient segmentation approach built in the project set the tone for future demand studies",
          "A standardized framework across geographies equipped the headquarter leadership to go to market with more forecasting confidence",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Global-Launch-Forecasting-_(5).pdf",
  },
  {
    id: 6,
    urlTitle: "Gross To Net (GTN) Modeling",
    img: "../caseStudiesAssets/gtn.webp",
    title:
      "Designing a dynamic tool for detailed gross to net revenue modelling",
    texts: [
      "All major pharmaceutical and biotech companies require an adaptive platform which would provide a clear view of flow of company’s Gross-to-Net financials. The “Gross to Net” (GTN), in its essence captures droppage accounted via promotional discounts and rebates",
      "Viscadia has developed a GTN calculation platform to analyse the demand and pricing KPIs in an all–encompassing interactive GTN dashboard. It is designed to address all nuances related to federal rebates per US government policies.",
    ],
    mainSubtitle:
      "Specialized platform to calculate and aggregate commercial and federal discounts to understand revenue droppage",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Federal.png",
        title: "Federal channels",
        texts: [
          "Accommodating inputs around varying federal discounts across different channels",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Inventory-1.png",
        title: "Inventory consideration",
        texts: [
          "Effectively incorporating inventory dynamics across channels and understanding demand distribution across channels",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/ASP.png",
        title: "Average selling price (ASP)",
        texts: [
          "Formulating relationship between Wholesaler Acquisition Cost (WAC) and various rebates and chargebacks to estimate Average Selling Price (ASP) across channels",
        ],
      },
    ],
    approach: [
      {
        title: "Channel segmentation",
        texts: [
          "Accommodated various  channels across nodes of distribution network during the flow of drug from manufacturer to the patient",
        ],
      },
      {
        title: "Discount calculations",
        texts: [
          "Incorporated operational nuances in the tool for different federal and non-federal channels to derive respective rebates/ discounts",
        ],
      },
      {
        title: "Standardization route",
        texts: [
          "Created a robust methodology  to enable the user to function at Stock Keeping Unit (SKU) as well as Standard Unit (SU) level across various channels",
        ],
      },
      {
        title: "Forward looking tool",
        texts: [
          "Ensured tool is equipped to forecast GTN for forthcoming years thus enabling user to devise well-informed strategies",
        ],
      },
      {
        title: "Central repository",
        texts: [
          "Created a one stop repository for all the KPIs, related to GTN, for downstream usage by finance and forecast teams",
        ],
      },
      {
        title: "Scenario modelling",
        texts: [
          "Provided functionality that provides user the flexibility to  configure and compare different what-if scenarios on the fly",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "A comprehensive tool with insights and outputs enabling analysis of GTN evolution over time.",
          "Accounting summary to help visualize the flow of discounts from top-line to bottom-line across each indication & channel as well as at overall level",
          "User manual providing extensive documentation of model design and operation to facilitate easy knowledge transfer",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Formulated ASP calculation and contractual relationship between Clinics & Group Purchasing Organizations (GPOs)",
          "Provided functionality to define custom drug distribution network, input pricing and SKU assumptions as required to understand discount impacts on Net revenue",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Immediate impact: GTN would serve as an end-to-end tool to understand revenue droppage across various ends and channels and shape commercial strategy",
          "Long Term Impact: GTN optimization would enable company leadership to make informed decisions, not only to drive the bottom-line growth but also to enhance competitive market positioning",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Gross-To-Net-GTN-Modeling-_(6).pdf",
  },
  {
    id: 7,
    urlTitle: "Long Range Forecast Planning",
    img: "../caseStudiesAssets/Long-Range-Forecast-Planning.webp",
    title: "Long range planning platform for portfolio assessment",
    texts: [
      "A leading international biotech company wanted an adaptive platform which would provide a real-time depiction of the company’s financials based on the performance of 30+ product-indication combinations having a market worth of around $2B.",
      "Viscadia was asked to design and build a scalable and dynamic long-range planning model which would aggregate the product and firm level financials from cross-functional stakeholders in order to create an all – encompassing portfolio dashboard.",
    ],
    mainSubtitle:
      "Singular platform to synthesize and aggregate asset level forecasts and expenses to support long range planning.",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Deal.png",
        title: "Deal structures",
        texts: [
          "Formulating a flexible and scalable design to accommodate inputs across varying deal structures and partnerships; including but not limited to – royalty, milestone, upfront payment, cost sharing etc.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Asset.png",
        title: "Asset standardization",
        texts: [
          "Categorizing and incorporating the plethora of assets, each varying in aspects such as stage in product life cycle, launch year, modeling complexity etc. onto a standardized template which can be leveraged to efficiently add/edit assets over time.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Portfolio-1.png",
        title: "Portfolio management & analysis",
        texts: [
          "Aggregating asset and firm level dynamics while accounting for their respective synergies to create a singular yet comprehensive picture of the company portfolio.",
        ],
      },
    ],
    approach: [
      {
        title: "Asset segmentation",
        texts: [
          "Classified and segmented the assets on basis of their stage of development, deal structure and forecast availability, and mapped the segments to a forecast approach and appropriate financial template.",
        ],
      },
      {
        title: "Profit sharing",
        texts: [
          "Incorporated asset specific profit-sharing deal structures to track revenue and expenses as a result of partnerships and support a clear depiction of the financial performance.",
        ],
      },
      {
        title: "Asset templatization",
        texts: [
          "Built a base standard template to house asset level financials and facilitate data collation and representation across all asset types – to ensure consistency and scalability.",
        ],
      },
      {
        title: "Central repositor",
        texts: [
          "Created a one stop repository for all the financial inputs related to different assets to make the user experience more streamlined and hassle free.",
        ],
      },
      {
        title: "Portfolio management",
        texts: [
          "Managed client’s complete portfolio through dynamic, individual asset level modelling and aggregation that caters to different cross functional needs",
        ],
      },
      {
        title: "Analyses support",
        texts: [
          "Provided frameworks to  configure multiple scenarios across different financial elements + Calculated portfolio specific KPIs (such as NPV) to measure the health of the business.",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Long Range Planning model with comprehensive set of insights and output views including comparator view that helped the user quantitatively compare changes between different models/scenarios with the help of waterfall charts.",
          "User manual providing extensive documentation to facilitate and support easy knowledge transfer and refresh in subsequent LRP cycles.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Enabled leadership to measure and reflect on historical performance and plan strategies for future years.",
          "Established streamlined processes to manage inputs and outputs across cross-functional stakeholders.",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Impact",
        texts: [
          "Built an extensive model that serves as the heart and core of Long-Range Planning (LRP) planning cycles at the client’s end till date.",
          "A self-sufficient automated framework that will continue to help the client to add/edit any new/existing assets for the next 5-10 years.",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Long-Range-Forecast-_(7).pdf",
  },
  {
    id: 8,
    urlTitle: "Strategy And Portfolio Optimization",
    img: "../caseStudiesAssets/portfolio.webp",
    title: "Patient-level forecasting for Four drugs with 1B+ in total revenue",
    texts: [
      "A top-10 global pharmaceutical company had multiple drugs in their Immunology Business Unit indicated for both acute and prophylactic treatments, including the market-leading therapy with $1B+ in annual revenue. They needed to better understand the impact of new entrants across the complete product portfolio.",
      "Viscadia was asked to design, build and deploy forecasting platforms that addressed the end-to-end forecasting needs of the full portfolio, including short-term evaluations, long-range planning, market forecasting and patient analytics.",
    ],
    mainSubtitle:
      "Informed key forecast drivers such as persistency, titration curves, and compliance through real time patient data",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Patientlevel.png",
        title: "Patient-level data capture",
        texts: [
          "Formulating business rules for translating raw patient data into key metrics such as new starts, continuing patients, drops, and more",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Evolving.png",
        title: "Evolving patient preference",
        texts: [
          "Modeling for a changing treatment paradigm; addressing migration of a considerable patient population from acute treatment to prophylactic therapies",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Portfolio-1.png",
        title: "Portfolio management",
        texts: [
          "Managing evolving forecasting needs for all the drugs in the portfolio, with each drug located at a different position in their respective life cycles",
        ],
      },
    ],
    approach: [
      {
        title: "Patient flow modeling design",
        texts: [
          "Constructed comprehensive patient flow model, capturing complex fulfillment dynamic with intuitive UI design",
        ],
      },
      {
        title: "Cannibalization matrix",
        texts: [
          "Created cannibalization matrix to track movement of patients across different products and segments in market with new product launches",
        ],
      },
      {
        title: "Portfolio management",
        texts: [
          "Managed client’s complete portfolio through dynamic, individual forecasting models that cater to different cross-functional needs",
        ],
      },
      {
        title: "Market modeling",
        texts: [
          "Designed and built an integrated market forecast model to comprehensively evaluate the overall market, with a particular focus on the client’s portfolio and associated interplay between products",
        ],
      },
      {
        title: "Data extraction and deep dives",
        texts: [
          "Built capability to streamline data extraction and processing from multiple sources to ensure consistency. Informed key forecast drivers such as persistency, titration curves, and compliance —with ability to update them in real-time",
          "Performed deep dives into patient-level data to generate valuable new business KPIs",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Patient flow model with comprehensive set of insights, analytics, and output views ",
          "Market forecast model supporting evolving market landscape with view of patient switches and market share movement",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Incorporate trends from actual patient-level data into forecast planning and goal setting",
          "Provided constant support through multiple planning and budget cycles, helping turn around updates and refinements in a time-sensitive manner",
          "Designed and built custom event palette in market model to help configure events using either market research-driven insights or custom business inputs with scalability",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Accelerated timeline",
        texts: [
          "Reduced cycle time for data updates by 50% through automation and quality control management to ensure accurate forecasting",
          "Increased confidence of forecast assumptions by employing rigorous patient data analytics to test and validate business hypothesis",
          "Empowered leadership to seamlessly track the entire market and portfolio with real-time insights on its share of business",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Strategy-and-Portfolio-Optimization-_(8).pdf",
  },
  {
    id: 9,
    urlTitle: "Go-To-Market Model",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Go-to-market-forecast-model.webp",
    title:
      "Detailed patient-journey tracking and Forecasting for rare disease therapy",
    texts: [
      "A specialty pharmaceutical company was planning to launch an oral prescription medication for treatment of seizures associated with a rare pediatric disease. The market landscape included several non-pharmacological therapies and non-targeted drugs.",
      "Viscadia was asked to design and build a go-to-market forecasting model for tracking patient journeys and projecting demand on a weekly basis.",
    ],
    mainSubtitle:
      "Helped the client predict patient journey and product demand for a therapy in a $1B rare diseases market",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Complex-1.png",
        title: "Complex fulfillment process",
        texts: [
          "Modeling several steps in the patient fulfillment funnel of a small patient population including REMS, echocardiogram assessments, and payer benefit verification",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Complex-1.png",
        title: "Lack of history",
        texts: [
          "Formulating forecasting KPIs reflective of the entire population from a small sample size",
          "Building confidence on key forecast drivers",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Pandemic.png",
        title: "Pandemic impact",
        texts: [
          "Re-assessing pipeline forecast after product launch amid COVID-19 pandemic",
          "Refining patient fulfilment assumptions to adjust for the impact of restrictions due to the pandemic",
        ],
      },
    ],
    approach: [
      {
        title: "Patient fulfillment pathway mapping",
        texts: [
          "Conducted detailed stakeholder discussions to understand and define various potential patient journey pathways",
        ],
      },
      {
        title: "Queue conversion modeling",
        texts: [
          "Tracked the patient acquisition forecast in the model by incorporating average patient-journey time across different pathways",
        ],
      },
      {
        title: "Short and long-term patient forecasting",
        texts: [
          "Assessed therapy-area nuances, patient segments, clinical and commercial drivers of product usage, and estimated both near- and long-term KPIs",
        ],
      },
      {
        title: "Variance analysis",
        texts: [
          "Triangulated forecasts against actual weekly data, refined forecast assumptions and facilitated monthly and quarterly forecast updates",
        ],
      },
      {
        title: "Cross-functional insights and planning",
        texts: [
          "Mapped the forecast model back to HCP segments for targeting, creating guidance for sales teams and optimizing patient access efforts",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "ViscadiaPatient Diagnostics Dashboard (Refreshed monthly)",
          "Viscadia Regional Forecast Models (Refreshed weekly)",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Enabled leadership to track and incorporate trends from the actual patient data into forecast planning and goal setting",
          "Facilitated patient analytics to answer post-launch business questions faced by C-Suite leadership for board meetings and earnings calls",
          "Helped commercial leaders quantitatively simulate what-if scenarios to assess market trends during COVID-19",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "The forecast model enabled comprehensive and intuitive evaluation of key performance indicators and helped drive stakeholder decisions",
          "Established Viscadia’s forecast platform as a go-to tool for simulating forecast scenarios by senior leadership",
          "Allowed the commercial team to detect bottlenecks in the patient fulfillment process in real time",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Go-to-Market-_(9).pdf",
  },
  {
    id: 10,
    urlTitle: "Global Oncology Forecasting",
    img: "../caseStudiesAssets/Viscadia-Case-Study-Global-Oncology-Forecast-Model.webp",
    title:
      "Building forecasting capabilities for a complex oncology patient flow",
    texts: [
      "A global biotechnology company wanted to forecastmarket potential for their oral TKI inhibitor of the HER2 protein, which had been approved for oncology indication for all major markets.",
      "Viscadia was asked to design and build an epidemiology-based patient flow model to construct a market landscape and assess product potential across 22 different markets around the world, while also incorporating regional nuances specific to several key markets.",
    ],
    mainSubtitle:
      "Streamlined forecasting processes for a global oncology asset with ~$1.5B total revenue spread across 22 geographies",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Complex.png",
        title: "Complex treatment paradigm",
        texts: [
          "Tracking patients across multiple lines of therapy",
          "Segmenting eligible patients based on treatment history",
          "Incorporating nuances critical to oncology forecasting such as participation in clinical trials, patient warehousing, and bolus patient switching",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Lack.png",
        title: "Lack of global forecasting framework",
        texts: [
          "Regional stakeholders leveraged independent forecasting processes leading to multiple disconnected forecasting narratives",
          "Incorporating region-specific nuances such as affordability, patient access, seasonality, and differential SKU size",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Gotomodel.png",
        title: "Go-to-market modeling",
        texts: [
          "Reconciling forecast with actual demand units post-launch",
          "Triangulating demand forecast with the account level, bottoms up forecast",
        ],
      },
    ],
    approach: [
      {
        title: "Patient flow model",
        texts: [
          "Designed and built a comprehensive patient flow forecast model, allowing in-depth tracking of patient metrics (such as naïve and experienced patients, and more) across multiple lines of therapy",
        ],
      },
      {
        title: "Regional forecast harmonization",
        texts: [
          "Engaged with stakeholders to understand strategic imperatives and developed a forecasting framework that could scale across geographies",
        ],
      },
      {
        title: "Global forecast platform",
        texts: [
          "Automated the aggregation of 22 regional models with the global forecast to facilitate decision making at headquarters",
        ],
      },
      {
        title: "Refining forecast assumptions",
        texts: [
          "Performed deep-dives and set up analytical processes to continuously refine key forecasting assumptions, including projections for SKU-level demand and bolus patients",
        ],
      },
      {
        title: "Scenario planning and optimization",
        texts: [
          "Equipped the regional and global models with the functionality to simulate what-if scenarios, review KPIs, and assess key forecast drivers",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Viscadia Global Forecast Model (For headquarters)",
          "Viscadia Regional Forecast Models (For individual countries)",
          "Monthly, Quarterly, and Annual Forecasts (For corporate planning)",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Streamlined the global forecasting process through deep collaboration",
          "Developed new forecasting infrastructure and facilitated stakeholder onboarding",
          "Successfully partnered with the client to faciliate the budgeting and corporate planning process",
          "Advised the client for cross-functional business needs including sales force target optimization and inventory planning",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "The forecast model enabled comprehensive and intuitive evaluation of key performance indicators and helped drive stakeholder decisions",
          "Established an end-to-end forecasting process which eventually defined best practices across multiple pipeline and on-market assets",
          "Viscadia was chosen as an overarching partner to supervise forecast data reporting, corporate planning and commercial analytics",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Global-Oncology-Forecasting-_(10).pdf",
  },
  {
    id: 11,
    urlTitle: "Pain Management Portfolio Forecast",
    img: "../caseStudiesAssets/pain-management.webp",
    title:
      "Designing a specialized forecast model for pain management portfolio",
    texts: [
      "An upcoming specialty pharmaceutical firm was looking to elevate its forecasting infrastructure for its pain management portfolio.",
      "Viscadia designed and built a statistical trend-based forecast platform for predicting demand across different channels. While accounting for market, product or channel level event impacts. Furthermore, it granted the capability to download essential summaries and execute comprehensive calculations quickly.",
    ],
    mainSubtitle:
      "A comprehensive inline model that incorporates the synergistic effect of product/market and contracting events.",
    challenges: [
      {
        img: "../caseStudiesAssets/detailsImages/Data-Reconc.png",
        title: "Data reconciliation",
        texts: [
          "Utilizing multiple sources and flavors of data to prepare the repository for the baseline trend forecast",
          "Lack of unified datasets to bridge payer and PBM accounts to pertinent product-contract-level mapping",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Trend-Forecasting.png",
        title: "Trend forecasting",
        texts: [
          "Incorporating an integrated stand-alone data trending tool within the primary model",
          "Reducing the clutter around using multiple spreadsheets every time refreshing the forecast",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Lackprocess.png",
        title: "Lack of forecast process",
        texts: [
          "Process to compare forecasts across Quarterly cycles to ascertain change drivers",
          "Unified solution to assist in both short-term and long-term forecasts for business planning",
        ],
      },
    ],
    approach: [
      {
        title: "Data triangulation",
        texts: [
          "Triangulated demand, ex-factory and distributor data to prepare inputs for trending. Automated data processing to build data pipeline and adjust for capture rates",
        ],
      },
      {
        title: "Integrating trending tool",
        texts: [
          "Designed an integrated and robust statistical palette to generate baseline forecast as part of the inline model, embedding it within the primary framework",
        ],
      },
      {
        title: "Comparison cycles for LBE",
        texts: [
          "Built in modular fashion to visualize and draw comparison across different forecast versions. Adjunct waterfall views to assist in compartmentalizing the deviation",
        ],
      },
      {
        title: "Automation capabilities",
        texts: [
          "Devised user-friendly automation in the model to enhance model usability and accessibility while not compromising the transparency of the flow",
        ],
      },
      {
        title: "Event modelling",
        texts: [
          "Developed a comprehensive module to weigh in impact of key events for market, product and contracting events and assimilated it within the model",
        ],
      },
    ],
    outcomes: [
      {
        img: "../caseStudiesAssets/detailsImages/End-Deliverable.png",
        title: "End deliverables",
        texts: [
          "Pain Management Portfolio Forecast Model",
          "Short-term and Long-term forecasts (for better planning)",
          "Infrastructure to process and crunch rebates data for using it within the primary framework for informing GTN assumptions",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Key-highlights.png",
        title: "Key highlights",
        texts: [
          "Developed a robust model to enhance forecasting process and manage multiple products and assumptions pertaining around them.",
          "Successfully partnered with the client to assist in transitioning their forecast process, for efficiently executing short-term and long-range forecast cycles",
        ],
      },
      {
        img: "../caseStudiesAssets/detailsImages/Impact.png",
        title: "Impact",
        texts: [
          "Enabled the client to visualize the impact of business events using the provided functionality",
          "Decluttered and simplifying the repetitive forecast process. Reduced the forecast turn around time by 80%",
          "Framework to extract executive-level summary from the model itself, enabled the client to work with multiple stakeholders",
        ],
      },
    ],
    pdf: "../pdf/case-study-pdf/Viscadia_CaseStudy_Pain-Management-Portfolio-_(11).pdf",
  },
];

export const whitePapersData = [
  {
    id: 1,
    title: "PAYERS AND THE INFLATION REDUCTION ACT",
    text: "Initial Perspectives and Forecast Implications",
    img: "../caseStudiesAssets/whitePaper/Viscadia_whitepaper-cover-image_PAYERS-297x384.png",
    pdf: "./pdf/white-paper/Viscadia_White-Paper_Payers-and-the-Inflation-Reduction-Act_R2.pdf",
  },
  {
    id: 2,
    title: "THE UPCOMING CROWDED PIPELINE CRISIS AND WHAT TO DO ABOUT IT",
    text: "A Forecaster’s Perspective",
    img: "../caseStudiesAssets/whitePaper/WP_Thumbnail-297x384.png",
    pdf: "./pdf/white-paper/Viscadia_WhitePaper_Upcoming-Crowded-Pipeline-Crisis.pdf",
  },
  {
    id: 3,
    title:
      "OPTIMIZING EARLY-STAGE COMMERCIAL ASSESSMENTS FOR EMERGING BIOPHARMA",
    text: "",
    img: "../caseStudiesAssets/whitePaper/WP_Thumbnail-1-297x384.png",
    pdf: "./pdf/white-paper/Viscadia_Whitepaper_Optimising-Early-Stage-Commercial-Assessments.pdf",
  },
];
